PP2A-Mediated Regulation of Ras Signaling in G2 Is Essential for Stable Quiescence and Normal G1 Length
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
SUMMARY Quiescence (G0) allows cycling cells to reversibly cease proliferation. A decision to enter quiescence is suspected of occurring early in G1, before the restriction point, R. Surprisingly, we have identified G2 as an interval during which inhibition of the protein phosphatase, PP2A, results in failure to exhibit stable quiescence. This effect is accompanied by shortening of the ensuing G1. The PP2A subcomplex required for stable G0 contains the B56γ B subunit. Following PP2A inhibition in G2, aberrant overexpression of cyclin E occurs during mitosis and is responsible for overriding quiescence. Strikingly, suppression of Ras signaling re-establishes normal cyclin E levels during M and restores G0. These data point to PP2A-B56γ-driven Ras signaling-modulation in G2 as essential for suppressing aberrant cyclin E expression during mitosis and, thereby, achieving normal G0 control. Thus, G2 is an interval during which the length and growth factor dependence of the next G1 interval are established.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chen, W., Arroyo, J. D., Timmons, J. C., Possemato, R., & Hahn, W. C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1103 · Cited by 159 · cited 2×
“Others have observed increased levels of p-AKT (Chen et al., 2005; Sablina et al., 2010) and p-ERK (Letourneux et al., 2006) in the absence of PP2A-B56g after brief pulses of serum starvation and restimulation.”
BackgroundSelf-citationRetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Coexistence of Quiescent and Active Adult Stem Cells in Mammals
Li, L., & Clevers, H. (2010) · Science · doi:10.1126/science.1180794 · Cited by 1,247 · cited 2×
“Growing evidence suggests that stem cells in most tissues also utilize quiescence as a means by which to achieve cell-cycle arrest between periods of proliferation (Jude et al., 2008; Li and Clevers, 2010).”
BackgroundFry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · cited 1×
“Furthermore, addition of the Cdk4/6-specific inhibitor PD0332991 (Fry et al., 2004) during late G2/M failed to prevent OA-mediated G0 bypass, indicating that this aberrant manifestation of proliferation was independent of cyclin D-Cdk4/6 activity (Figure S6D).”
BackgroundYeh, E., Cunningham, M., Arnold, H., Chasse, D., Monteith, T., Ivaldi, G., Hahn, W. C., Stukenberg, P. T., Shenolikar, S., Uchida, T., et al. (2004) · Nature Cell Biology · doi:10.1038/ncb1110 · Cited by 791
Self-citationCIP2A inhibits PP2A in human malignancies
Junttila, M. R., Puustinen, P., Niemelä, M., Ahola, R., Arnold, H., Böttzauw, T., Ala-aho, R., Nielsen, C., Ivaska, J., Taya, Y., et al. (2007) · Cell · doi:10.1016/j.cell.2007.04.044 · Cited by 677 · cited 3×
“How is Myc upregulated in this setting? Myc is known to be dephosphorylated by PP2A, promoting its degradation (Junttila et al., 2007; Yeh et al., 2004).”
BackgroundLitovchick, L., Sadasivam, S., Florens, L., Zhu, X., Swanson, S. K., Velmurugan, S., Chen, R., Washburn, M. P., Liu, X. S., & DeCaprio, J. A. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.04.015 · Cited by 396 · cited 5×
“Two members of the MuvB complex (LIN9 and LIN37) are normally bound to p130 and E2F4 in G0 and contribute to G0 maintenance (Litovchick et al., 2007).”
BackgroundSelf-citationKuo, Y.-C., Huang, K.-Y., Yang, C.-H., Yang, Y.-S., Lee, W.-Y., & Chiang, C.-W. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709585200 · Cited by 367
Identification of specific PP2A complexes involved in human cell transformation
Chen, W., Possemato, R., Campbell, K. T., Plattner, C. A., Pallas, D. C., & Hahn, W. C. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00026-1 · Cited by 325 · cited 2×
“Phosphatase Assay PP2A assays were performed as described in Chen et al. (2004).”
BackgroundMethodSelf-citationArnold, H. K., & Sears, R. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2832-2844.2006 · Cited by 251 · cited 2×
“Although several PP2A B subunits are involved in modulating Ras signaling (Arnold and Sears, 2006; Kuo et al., 2008; Letourneux et al., 2006; Sablina et al., 2010), a screen employing shRNAs that targeted much of the B subunit complement revealed B56g as the one subunit of this group whose depletion was able to phenoc…”
BackgroundIdentification of PP2A Complexes and Pathways Involved in Cell Transformation
Sablina, A. A., Hector, M., Colpaert, N., & Hahn, W. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2855 · Cited by 193
Self-citation
Research works printed but not linked: 31
- Avni, 2003, Active localization of the retinoblastoma protein in chromatin and its response to S phase DNA damage, Mol. Cell, 12, 735, 10.1016/S1097-2765(03)00355-1 · DOI
- Brooks, 1977, Continuous protein synthesis is required to maintain the probability of entry into S phase, Cell, 12, 311, 10.1016/0092-8674(77)90209-4 · DOI · Paper page
- Chan, 2005, The p400 E1A-associated protein is a novel component of the p53 —> p21 senescence pathway, Genes Dev., 19, 196, 10.1101/gad.1280205 · DOI · Paper page
- Coller, 2006, A new description of cellular quiescence, PLoS Biol., 4, e83, 10.1371/journal.pbio.0040083 · DOI · Paper page
- Eichhorn, 2009, Protein phosphatase 2A regulatory subunits and cancer, Biochim. Biophys. Acta, 1795, 1
- Feig, 1988, Inhibition of NIH 3T3 cell proliferation by a mutant ras protein with preferential affinity for GDP, Mol. Cell. Biol., 8, 3235
- Georlette, 2007, Genomic profiling and expression studies reveal both positive and negative activities for the Drosophila Myb MuvB/dREAM complex in proliferating cells, Genes Dev., 21, 2880, 10.1101/gad.1600107 · DOI · Paper page
- Hahn, 2002, Enumeration of the simian virus 40 early region elements necessary for human cell transformation, Mol. Cell. Biol., 22, 2111, 10.1128/MCB.22.7.2111-2123.2002 · DOI · Paper page
- Hitomi, 1999, Cellular ras and cyclin D1 are required during different cell cycle periods in cycling NIH 3T3 cells, Mol. Cell. Biol., 19, 4623, 10.1128/MCB.19.7.4623 · DOI
- Janssens, 2001, Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling, Biochem. J., 353, 417, 10.1042/bj3530417 · DOI · Paper page
- Jude, 2008, Leukemia and hematopoietic stem cells: balancing proliferation and quiescence, Cell Cycle, 7, 586, 10.4161/cc.7.5.5549 · DOI
- Korenjak, 2004, Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes, Cell, 119, 181, 10.1016/j.cell.2004.09.034 · DOI · Paper page
- Letourneux, 2006, B56-containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX-1 and ERK, EMBO J., 25, 727, 10.1038/sj.emboj.7600980 · DOI · Paper page
- Malumbres, 2001, To cycle or not to cycle: a critical decision in cancer, Nat. Rev. Cancer, 1, 222, 10.1038/35106065 · DOI · Paper page
- Matallanas, 2003, Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization, J. Biol. Chem., 278, 4572, 10.1074/jbc.M209807200 · DOI
- Merrick, 2011, Switching Cdk2 on or off with small molecules to reveal requirements in human cell proliferation, Mol. Cell, 42, 624, 10.1016/j.molcel.2011.03.031 · DOI
- Mungre, 1994, Mutations which affect the inhibition of protein phosphatase 2A by simian virus 40 small-t antigen in vitro decrease viral transformation, J. Virol., 68, 1675, 10.1128/jvi.68.3.1675-1681.1994 · DOI · Paper page
- Ohtsubo, 1993, Cyclin-dependent regulation of G1 in mammalian fibroblasts, Science, 259, 1908, 10.1126/science.8384376 · DOI · Paper page
- Pardee, 1974, A restriction point for control of normal animal cell proliferation, Proc. Natl. Acad. Sci. USA, 71, 1286, 10.1073/pnas.71.4.1286 · DOI · Paper page
- Pérez-Roger, 1997, Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes, Oncogene, 14, 2373, 10.1038/sj.onc.1201197 · DOI · Paper page
- Sablina, 2008, SV40 small T antigen and PP2A phosphatase in cell transformation, Cancer Metastasis Rev., 27, 137, 10.1007/s10555-008-9116-0 · DOI
- Sablina, 2007, The tumor suppressor PP2A Abeta regulates the RalA GTPase, Cell, 129, 969, 10.1016/j.cell.2007.03.047 · DOI · Paper page
- Sadasivam, 2012, The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression, Genes Dev., 26, 474, 10.1101/gad.181933.111 · DOI · Paper page
- Sakaue-Sawano, 2008, Visualizing spatiotemporal dynamics of multicellular cell-cycle progression, Cell, 132, 487, 10.1016/j.cell.2007.12.033 · DOI · Paper page
- Sears, 2000, Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability, Genes Dev., 14, 2501, 10.1101/gad.836800 · DOI · Paper page
- Soucek, 1998, Design and properties of a Myc derivative that efficiently homodimerizes, Oncogene, 17, 2463, 10.1038/sj.onc.1202199 · DOI · Paper page
- Spencer, 2013, The proliferation-quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit, Cell, 155, 369, 10.1016/j.cell.2013.08.062 · DOI · Paper page
- Stein, 1979, T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro, J. Cell. Physiol., 99, 43, 10.1002/jcp.1040990107 · DOI · Paper page
- Yao, 2008, A bistable Rb-E2F switch underlies the restriction point, Nat. Cell Biol., 10, 476, 10.1038/ncb1711 · DOI · Paper page
- Yu, 2001, Critical role for SV40 small-t antigen in human cell transformation, Virology, 290, 192, 10.1006/viro.2001.1204 · DOI
- Zetterberg, 1985, Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells, Proc. Natl. Acad. Sci. USA, 82, 5365, 10.1073/pnas.82.16.5365 · DOI · Paper page
Cited by
The same, only different – DNA damage checkpoints and their reversal throughout the cell cycle
Shaltiel, I. A., Krenning, L., Bruinsma, W., & Medema, R. H. (2015) · Journal of Cell Science · doi:10.1242/jcs.163766 · Cited by 294
Integrating Old and New Paradigms of G1/S Control
Rubin, S. M., Sage, J., & Skotheim, J. M. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.08.020 · Cited by 264
Cell cycle transcription control: DREAM/MuvB and RB-E2F complexes.
Fischer, M., & Müller, G. A. (2017) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2017.1360836 · Cited by 255
PP2A inhibition is a druggable MEK inhibitor resistance mechanism in KRAS-mutant lung cancer cells
Kauko, O., O’Connor, C. M., Kulesskiy, E., Sangodkar, J., Aakula, A., Izadmehr, S., Yetukuri, L., Yadav, B., Padzik, A., Laajala, T. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aaq1093 · Cited by 149
Oncoprotein CIP2A is stabilized via interaction with tumor suppressor PP2A/B56
Wang, J., Okkeri, J., Pavic, K., Wang, Z., Kauko, O., Halonen, T., Sarek, G., Ojala, P. M., Rao, Z., Xu, W., et al. (2017) · The EMBO Reports · doi:10.15252/embr.201642788 · Cited by 95
Metadata
- Authors
- Naetar, N., Soundarapandian, V., Litovchick, L., Goguen, K. L., Sablina, A. A., Bowman-Colin, C., Sicinski, P., Hahn, W. C., DeCaprio, J. A., & Livingston, D. M.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2014-06
- Volume
- 54
- Issue
- 6
- Pages
- 932-945
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2017707134
- Cited by
- 67
- References
- 11
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 383 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- Austrian Science Fund
- National Cancer Institute
- Österreichischen Akademie der Wissenschaften
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.